From the Summary: "Consumers and news outlets had questions and concerns about the SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] Omicron variant. The COVID-19 [coronavirus disease 2019] State of Vaccine Confidence Insights Rapid SARS-CoV-2 Omicron Variant Report was published on December 10, 2021[.] [...] Additionally, the public continued to have questions and expressed frustration about vaccine guidance. Consumers also expressed growing interest in using alternatives to the COVID-19 vaccines, such as therapeutics and infection-acquired immunity. Finally, consumers continue to have questions and concerns about COVID-19 vaccines for children and COVID-19 vaccine booster doses. [...] Federal, state, and local partners should continue to work together to explain the rationale for updated guidance, respond to gaps in information, and confront misinformation with evidence-based messaging. The goal of these efforts is to increase confidence in COVID-19 vaccines and expand vaccine uptake more broadly. To increase vaccine confidence and optimize clinical encounters, continue to disseminate messages about the safety of receiving the COVID-19 and flu vaccines at the same appointment for adults and children. Finally, partner with trusted messengers, especially pharmacists, vaccine champions, and healthcare workers, to increase their knowledge regarding the safety of receiving the COVID-19 and flu vaccines at the same appointment and communicate this to the public."
COVID-19 State of Vaccine Confidence Insights Report No. 20
Centers for Disease Control and Prevention: https://www.cdc.gov/